We measured time-kills and postantifungal effects (PAFEs) of caspofungin against Candida albicans, C. parapsilosis, and C. glabrata isolates. One-hour exposure to caspofungin during PAFE experiments accounted for the majority of killing during time-kill experiments. Regrowth of all isolates was inhibited for at least 24 h following drug washout.
100 l was obtained from each solution, serially diluted, and plated on SDA plates for colony enumeration. We simultaneously set up time-kill and PAFE experiments for control testing (no drug) and testing at 0.25, 1, 4, and 16 times the MIC in duplicate tubes (labeled "time-kill" and "PAFE"). After 1 hour of incubation, we centrifuged the cells in the "PAFE" tubes at 1,400 ϫ g for 10 min, washed them three times, and resuspended them in warm RPMI medium (9 ml) prior to a Ratio of the log killing during PAFE experiments to the log killing during time-kill experiments.
b NA, not applicable; there were no reductions in colony counts compared to the starting inoculum.
c Representative data for each isolate from one of at least two separate experiments are shown.
reincubation. Both sets of tubes were plated on SDA plates after 2, 4, 8, 12, and 24 h for CFU determination. Time-kill and PAFE experiments were conducted at least twice for each isolate.
During time-kill experiments, caspofungin at concentrations of 4 and 16 times the MIC caused significant reductions in the starting inoculum of each isolate ( Table 2 ). The extent of killing did not correlate with the MIC. Representative kill curves for time-kill experiments are shown in Fig. 1A and 2A .
During PAFE experiments, 1-hour exposure of all isolates to caspofungin at 4 and 16 times the MIC also caused large reductions in colony counts that persisted for the 24-h testing period (Table 2 ; Fig. 1B and 2B) . Moreover, the PAFE after a 1-hour exposure generally accounted for the majority of killing observed during time-kill experiments ( Table 2) . At 16 times the MIC, for example, a 1-hour exposure to caspofungin resulted in colony count reductions that were 37 to 100% of those seen with continuous 24-h exposure; similar results were obtained at 4 times the MIC and at the MIC.
For each isolate, we retested selected colonies that were not killed by exposure to caspofungin during time-kill and PAFE experiments. MICs of the "persisters" were identical to the MIC of the parent strain. Growth rates of the persisters were also indistinguishable from those of the parent strains at both 30 and 35°C.
The most notable findings of this study are the PAFEs we demonstrated. As in previous reports, caspofungin exerted prolonged PAFEs against C. albicans (1, 8). We found similar PAFEs against C. parapsilosis and C. glabrata isolates. More strikingly, 1-hour exposure to caspofungin accounted for up to 100% of the overall killing observed during time-kill experiments and inhibited regrowth of isolates for at least 24 h. The results are consistent with a rapid onset of sustained anticandidal activity by caspofungin, which might be explained by different mechanisms. As one mechanism, caspofungin might rapidly associate with its target and exert prolonged effects on the ␤-1,3-D-glucan synthase enzyme complex. Alternatively, the drug, as a large lipopeptide with a fatty acid side chain (5), could rapidly intercalate with the phospholipid bilayer of the candidal cell membrane and subsequently access its target over time. Regardless of the specific mechanism, caspofungin, similar to ␤-lactams (9, 10, 18) , is likely to be most active against proliferating cells, which would be consistent with our observation that killing increased over several hours.
It is also notable that persister Candida isolates that were not killed by caspofungin did not exhibit elevated MICs upon on October 1, 2017 by guest http://aac.asm.org/ retesting, indicating that growth was not due to acquired resistance or preexisting resistant subpopulations. Rather, it is possible that persisters were dormant or replicated slowly in the presence of caspofungin (4, 17, 19) . If so, they were not irreversibly impaired, as growth in liquid media after recovery from time-kill and PAFE experiments was not reduced. We demonstrated that caspofungin at concentrations above the MICs significantly reduced the burden of all eight Candida isolates during time-kill experiments. These reductions, however, did not fulfill strict definitions of fungicidal activity (i.e., Ն3-log reduction) (11) . Previous studies have shown that caspofungin exhibits fungicidal or fungistatic activity depending on the isolate and test conditions (2, 3, 7, 17) . Echinocandins are less consistently fungicidal in RPMI medium than antibiotic medium 3 (7, 8, 17) . Incubation times can also influence results, as indicated by our finding that prolonged incubation of 48 h did achieve fungicidal activity against at least one isolate (C. albicans S) (data not shown). In assessing our results, it is notable that concurrent time-kill experiments on several isolates with the fungistatic agent fluconazole were consistent with growth inhibition but failed to show reductions in starting inocula (data not shown).
Although the clinical implications of in vitro killing and PAFEs are unproven (1), our data suggest that treatment strategies that both optimize caspofungin peak concentrations and account for prolonged growth inhibition might be the best approach to candidiasis. As such, less-frequent administration of larger, cumulative doses might be at least as efficacious as more-frequent, smaller doses, especially given the persistence of caspofungin within tissues in vivo (13) . This conclusion is consistent with results of a recent pharmacodynamic study of caspofungin during murine candidiasis (13) . Trials comparing high-dose, once-or twice-weekly caspofungin regimens against standard daily dosing should be considered. 
